Skip to main content
Signal8
TYLE PRAVEEN profile photo

Praveen Tyle

CIK: 0001296936

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

KIORA PHARMACEUTICALS INC logo
KPRX

KIORA PHARMACEUTICALS INC

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • KIORA PHARMACEUTICALS INC logo
    KPRX

    KIORA PHARMACEUTICALS INC

    Jun 10, 2026
    Award(A)

    Stock Option (right to buy)

    Direct
    40K shares-
  • KIORA PHARMACEUTICALS INC logo
    KPRX

    KIORA PHARMACEUTICALS INC

    Apr 1, 2025
    Award(A)

    Stock Option (right to buy)

    Direct
    30K shares-

1-2 of 2

About TYLE PRAVEEN

TYLE PRAVEEN (SEC CIK 0001296936) files insider reports with the SEC as Director of KIORA PHARMACEUTICALS INC (KPRX).

Signal8 holds 2 ownership filings by TYLE PRAVEEN, all Form 4s, filed between Apr 2, 2025 and Jun 12, 2026. Those filings report 2 transactions, from Apr 1, 2025 to Jun 10, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on TYLE PRAVEEN's filings is in ENCINITAS, CA.

Recent filings by TYLE PRAVEEN

  • Jun 10, 2026: Grant or award of KPRX derivative securities (Form 4, code A).
  • Apr 1, 2025: Grant or award of KPRX derivative securities (Form 4, code A).

Other insiders filing for KIORA PHARMACEUTICALS INC (KPRX)

How to read Form 4 transaction codes